Congenital hemolytic anemia

Clinical trials for Congenital hemolytic anemia explained in plain language.

Never miss a new study

Get alerted when new Congenital hemolytic anemia trials appear

Sign up with your email to follow new studies for Congenital hemolytic anemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Nonmyeloablative allogeneic peripheral blood mobilized hematopoietic precursor cell transplantation for severe congenital anemias including sickle cell disease (SCD) and B-Thalassemia

Ongoing

People with severe congenital anemias, such as sickle cell anemia and beta-thalassemia, have been cured with bone marrow transplantation (BMT). The procedure, however, is limited to children younger than the age of 16 because the risks are lower for children than for adults. The…

Matched conditions: CONGENITAL HEMOLYTIC ANEMIA

Phase 1/2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Last updated Sep 09, 2026 15:00 UTC

Congenital hemolytic anemia

Get alerted when new Congenital hemolytic anemia trials appear

Nonmyeloablative allogeneic peripheral blood mobilized hematopoietic precursor cell transplantation for severe congenital anemias including sickle cell disease (SCD) and B-Thalassemia